Critical

Inhalational anthrax (bioterrorism)

Bioterrorism · Infectious Disease
Physician-written · Verified by three sets of doctors · Reviewed November 2026

Bedside summary

Bacillus anthracis spore inhalation causing a biphasic illness: flu-like prodrome then fulminant mediastinitis, haemorrhagic pleural effusions and shock. A deliberate-release/bioterrorism concern.

Red flags

  • Widened mediastinum on imaging in a previously well patient
  • Haemorrhagic pleural effusions
  • Meningeal signs (haemorrhagic meningitis)
  • Rapid progression to shock

Assessment

Differential diagnosis

  • Community-acquired pneumonia
  • Influenza/viral illness
  • Aortic dissection (widened mediastinum)
  • Tularaemia/plague (bioterrorism differentials)
  • Mediastinitis (other)

Investigations

  • Chest X-ray/CT (widened mediastinum, pleural effusions - not lobar infiltrate)
  • Blood cultures and Gram stain (large Gram-positive rods)
  • Pleural fluid analysis and culture
  • Notify public health and reference laboratory urgently
  • FBC, U&E, lactate, coagulation

Management

  • Isolate concern early and notify public health / reference lab (person-to-person spread is not the issue but exposure investigation is)
  • Resuscitate for sepsis; drain pleural effusions
  • Start combination IV antibiotics including a protein-synthesis inhibitor to reduce toxin
  • Add antitoxin (raxibacumab or anthrax immune globulin) per public health
  • Give steroids if extensive oedema/meningitis
  • ICU-level organ support

Drugs & doses

Ciprofloxacin IV plus clindamycin plus (if meningitis suspected) meropenem
Anthrax antitoxin (raxibacumab or obiltoxaximab) per public health
IV fluids and vasopressors as needed

Disposition

ICU; mandatory public health notification; prophylaxis planning for exposed contacts.

Complications & pitfalls

  • Haemorrhagic meningitis
  • Refractory shock and death
  • Massive pleural effusions

Exam pearls

  • Inhalational anthrax causes mediastinal widening rather than a classic pneumonia pattern.
  • Multiple simultaneous cases suggest deliberate release - notify authorities immediately.
  • Include a toxin-suppressing agent (e.g. clindamycin/linezolid) plus a bactericidal drug.

Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.